AzTrials
AzTrials

Respiratory DiseaseNCT04282369

Evaluation Of The Efficacy Of Four Different Non-invasive Ventilation Modes Performed In The Delivery Room

A study testing HHHFNC, NCPAP and NIPPV in people with Respiratory Disease and Respiratory Insufficiency, run by Kanuni Sultan Suleyman Training and Research Hospital at 2 sites in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation Of The Efficacy Of Four Different Non-invasive Ventilation Modes Performed In The Delivery Room In Late Preterm And Term Infants Wıth Respiratory Distress Read more about this study

Who is it for?
Ages Up to 2 hours
What is being tested?
HHHFNC, NCPAP and NIPPV
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesTurkey (Türkiye)
Study dates
18 Feb 2020to 15 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • late preterm and term infants with respiratory distress

Who cannot join

  • intubation for the respiratory distres.
  • major abnormalities

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites, 1 recruiting
  • Kanuni Sultan Suleyman Research and Training Hospital

    Istanbul, 34065

    Completed
  • Kanuni Sultan Suleyman Research and Training Hospital

    Istanbul

    ilker gönen, +905322054822, ilkergonen81@hotmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation Of The Efficacy Of Four Different Non-invasive Ventilation Modes Performed In The Delivery Room In Late Preterm And Term Infants Wıth Respiratory Distress

Evaluation Of The Efficacy Of Four Different Non-invasive Ventilation Modes Performed In The Delivery Room In Late Preterm And Term Infants Wıth Respiratory Distress

Read the detailed description

In this study, it is aimed to search the efficacy and comfort of the four different non-invasive ventilation modes in the delivery room. HHFNC, NCPAP, NIPPV and NHFO modes are used for the respiratory distress of the late preterm and term babies.

Being tested
HHHFNC, NCPAP, NIPPV, NHFO
Keywords
respiratory distress, newborn, noninvasive ventilation
Medical subject headings
Respiration Disorders, Respiratory Insufficiency, Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HHHFNCDevice

    noninvasive ventilation modality

  • NCPAPDevice

    noninvasive ventilation modality

  • NIPPVDevice

    noninvasive ventilation modality

  • NHFODevice

    noninvasive ventilation modality

Study groups in NCT04282369
Study groupRoleWhat they receive
HHFNCActive comparatorIn this group patients will receive respiratory support by high flow nasal cannula.
Receives: Device: HHHFNC
nCPAPActive comparatorIn this group patients will receive respiratory support by nasal CPAP.
Receives: Device: NCPAP
nIPPVActive comparatorIn this group patients will receive respiratory support by nasal IPPV.
Receives: Device: NIPPV
nHFOActive comparatorIn this group patients will receive respiratory support by nasal high frequency oscillatory. ventilation.
Receives: Device: NHFO

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Silverman Score

    The respiratory status of the newborns will be evaluated with the scoring system defined by Silverman.

    Measured: 6 months

Secondary outcomes (1)
  1. N-PASS score

    evaluation of the comfort of the four different noninvasive ventilation modes

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2020
  2. Study start18 Feb 2020
  3. Primary completion1 Aug 2020 (estimated)
  4. Study completion15 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04282369
Sponsor's protocol ID
32342545
Status last verified
Feb 2020
First submitted
17 Feb 2020
Last updated
24 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing HHHFNC, NCPAP and NIPPV in people with Respiratory Disease and Respiratory Insufficiency, run by Kanuni Sultan Suleyman Training and Research Hospital at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact ilker gönen (+905322054822, ilkergonen81@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Silverman Score (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04282369 | AzTrials